- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 764198
Total 1224 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminatedSafety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid ArthritisArthritis, RheumatoidUnited States, Belgium, Bulgaria, Germany, Greece, Netherlands, Poland, Portugal, Spain
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
AbbVieBoehringer IngelheimCompletedPsoriasisUnited States, Germany, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Dr Phillip J BuckhurstBMI Southend HospitalCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthy | AsthmaUnited Kingdom
-
Boehringer IngelheimNot yet recruitingIdiopathic Pulmonary Fibrosis | Progressive Pulmonary Fibrosis
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruitingLiposarcoma, DedifferentiatedUnited States, Australia, Canada, United Kingdom, Japan, Brazil, Argentina
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimActive, not recruitingBronchiectasisSpain, United States, Denmark, Belgium, Korea, Republic of, Canada, Italy, Japan, Bulgaria, Australia, Latvia, Netherlands, United Kingdom, Germany, Israel, France, Hungary, Mexico, Greece, Poland, Turkey, Czechia, Portugal
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
Boehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedNon-cystic Fibrosis BronchiectasisUnited Kingdom, Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedSafety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular EdemaMacular EdemaSpain, United Kingdom, Germany, Portugal, France, Belgium, Hungary, Greece
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetic RetinopathyUnited States, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Australia, Austria, France, Germany, New Zealand, Portugal, Romania, Spain, Switzerland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruitingPsoriasisBulgaria, Romania, Moldova, Republic of, Georgia
-
Northwell HealthRecruitingProstate Cancer | Magnetic Resonance Imaging | Population at RiskUnited States
-
Boehringer IngelheimRecruitingSolid TumorsUnited States, Japan, Canada
-
Boehringer IngelheimRecruitingNeoplasm Metastasis | Non-Small Cell Lung CancerUnited States, Hong Kong, Spain, Korea, Republic of, China, Israel, Germany, Japan, Singapore, Australia, United Kingdom, Austria, Netherlands, France, Portugal, Sweden, Italy, Belgium
-
Boehringer IngelheimCompletedPost-Traumatic Stress DisorderUnited States, Germany, Sweden, Finland, Israel, Poland, Mexico, Croatia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedBorderline Personality DisorderSpain, Germany, Sweden, United States, Mexico, Argentina, France, Poland, Australia, Belgium, Bulgaria, Czechia, Denmark, Italy, Japan